We see how the market reacts with a lower Net Profit HY26

Sales revenue up 1% (down 2% in CC*) to $1,176m

• Underlying net profit** down 9% to $195m

• Strong balance sheet with net cash of $173m

• Interim dividend steady at $2.15 per share

Underlying net profit is expected to be at the lower end of the $435-460 million guidance range provided in August 2025, reflecting the longer than anticipated contracting process for the Nexa Implant System in the first half 

https://hotcopper.com.au/threads/ann-hy26-result-presentation-slides.9017437/

Return (inc div)   1yr: -18.68%   3yr: 6.57% pa   5yr: 4.95% pa

Mkt cap !

$16.10B

Operating cash flow decreased $151.2 million to $237.6 million, with free cash flow decreasing $160.7 million to $122.4 million. 

https://hotcopper.com.au/threads/ann-annual-report-incl-sustainability-reporting.8712706/

The Cochlear Ltd (ASX: COH) share price is in focus today after the company reported FY25 sales revenue up 4% to $2,356 million and a 9% jump in statutory net profit to $389 million, with a 5% increase in full-year dividends.

What did Cochlear report?

• Sales revenue rose 4% to $2,356 million
• Statutory net profit up 9% to $389 million
• Underlying net profit increased 1% to $392 million, margin steady at 17%
• Final dividend of $2.15 per share, full-year dividend up 5% to $4.30 per share (72% payout)
• Cochlear implants shipped: 53,968 units, up 12%
• FY26 underlying net profit guidance: $435–460 million, up 11–17%

Return (inc div)   1yr: -8.01%   3yr: 13.44% pa   5yr: 10.23% pa